Biotech Force Danmark ApS: Financial statements 2016
CVR: 36434309
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
Biotech Force Danmark ApS (CVR 36434309) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,256,594 and a net result of DKK -378,154. Equity in the 2016 report amounted to DKK 6,291,017. The solvency ratio was 14.6%.
- Gross Profit
- DKK 1,256,594
- Profit/Loss
- DKK -378,154
- Equity
- DKK 6,291,017
- Total Assets
- DKK 43,146,474
Find more companies like Biotech Force Danmark ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
Biotech Force Danmark ApS has published its interim report for the period November 14, 2014 – December 31, 2015.
As of June 1, 2016, Joen-Magnus Reinert has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Nina Kjærgaard Reinert has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Anne Reinert Skovbakke has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Jette Kjærgaard has joined the board of directors of Biotech Force Danmark ApS.
As of June 1, 2016, Nina Kjærgaard Reinert is registered as adm. dir. of Biotech Force Danmark ApS.
As of June 1, 2016, Joen-Magnus Reinert has stepped down as director of Biotech Force Danmark ApS.
About Biotech Force Danmark ApS
Biotech Force Danmark ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2014. The company is registered under the industry Engroshandel med rengøringsmidler. The company was previously named ANTi-COVID 19 Danmark ApS and GL. DONSVEJ 6 KOLDING ApS. The management consists of Jette Kjærgaard. The company's owners include JMR HOLDING, KOLDING A/S, PLAN Invest A/S and Reinert Family Invest ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -3,515,065 and a net result of DKK -4,321,793 compared with DKK -2,161,531 the year before. Equity in the 2025 report amounted to DKK -18,527,805.